Hamlet Pharma secures Alpha1H production for continued clinical trials
It is a great pleasure to announce that Hamlet Pharma has secured the production of larger quantities of Alpha1H, using a stable, large scale manufacturing process. The new batches will be essential to extend the clinical trial program in patients with bladder cancer.The clinical trial program in bladder cancer is proceeding according to plan, using Alpha1H secured from previous production rounds. Larger amounts of Alpha1H will be needed moving forward, as the clinical trial program is expanding to involve larger patient numbers. As previsously announced, Hamlet Pharma is collaborating